Khalid Al Sulaiman, Khalid Al Sulaiman, Khalid Al Sulaiman, Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, . . . Hasan M. Al-Dorzi. (2022). The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study. Frontiers Media S.A..
Chicago Style (17th ed.) CitationKhalid Al Sulaiman, et al. The Impact of HMG-CoA Reductase Inhibitors Use on the Clinical Outcomes in Critically Ill Patients with COVID-19: A Multicenter, Cohort Study. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationKhalid Al Sulaiman, et al. The Impact of HMG-CoA Reductase Inhibitors Use on the Clinical Outcomes in Critically Ill Patients with COVID-19: A Multicenter, Cohort Study. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.